ONCOLife Issues
Featured Articles
Trending Articles
Sunvozertinib Outperforms Chemo in First-Line EGFR Exon 20 Insertion NSC Lung Cancer
ONCOLife | 22 March 2026
Magnetic Nanoparticle-Guided Hyperthermia Opens a New Path for Advanced Solid Tumors
ONCOLife | 23 March 2026
TG Therapeutics Secures $500M to Advance BRIUMVI in Relapsing Multiple Sclerosis
Biotech | 20 March 2026
Targeted Bladder Cancer Therapy Erda-iDRS Achieves 89% Response Rate and PDC
ONCOLife | 15 March 2026
Atirmociclib Reduces Progression Risk by 40% in CDK4/6 Metastatic Breast Cancer
ONCOLife | 17 March 2026
TALAPRO-3 Trial Supports Early Use of Talazoparib in HRR+ mCS Prostate Cancer
ONCOLife | 20 March 2026
FDA Approves Nivolumab-AVD as First Immunotherapy Combination for Hodgkin Lymphoma
FDA & EMA | 20 March 2026
Abenacianine Enters Phase 3 to Enhance Real-Time Tumor Detection in Lung Surgery
ONCOLife | 19 March 2026
CellCarta Secures Global Exclusivity for Aspyre Lung to Advance Lung Cancer Testing
Cancer | 18 March 2026
Vitamin B2’s Hidden Role in Cancer Survival May Open a New Therapeutic Target
ONCOLife | 14 March 2026
PSMA PET/CT May Transform Prostate Cancer Diagnosis and Reduce Biopsies by 50%
ONCOLife | 13 March 2026
Breast Cancer Patients Choosing Alternative Medicine Face Four Times Higher Mortality
ONCOLife | 9 March 2026
Designing Digital Healthcare Systems for the Future of Patient-Centered Care
Digital Health | 4 March 2026
Gut Bacteria Decide Whether Nutrients Feed Tumors or Fuel Immunity
ONCOLife | 13 February 2026
Novartis Expands US Radioligand Manufacturing With $23 Billion Investment in Florida
Pharma
9 January 2026
Rewiring RNA: Antisense RNA Therapy Exposes a New Weakness in Pancreatic Cancer
ONCOLife
8 January 2026
TRBC2-Specific ADC Shows Robust Efficacy in T-Cell Lymphomas and Leukemias
Clinical Trials
24 December 2025
Engineered Oncolytic Virus Reprograms Immunity and Extends Survival in Brain Cancer
ONCOLife
20 December 2025
Platinum-Free PADCEV Plus Pembrolizumab Improves Survival in MI Bladder Cancer
Clinical Trials
18 December 2025
Artificial Intelligence Detects Pancreatic Cancer More Accurately Than Radiologists
AI
12 December 2025
FDA Approves T-DXd Plus Pertuzumab as a First-Line Standard in HER2+ Breast Cancer
FDA & EMA
16 December 2025
Less Toxic, More Effective: RW Evidence Supports Reduced Immunotherapy Dose in Melanoma
Clinical Trials
14 December 2025
FDA Approves AKEEGA for BRCA2+ Prostate Cancer as the First Precision Therapy
FDA & EMA
12 December 2025
GSK’s ADC Risvutatug Rezetecan Earns FDA Orphan Drug Status for Small Cell Lung Cancer
FDA & EMA
10 December 2025
Ribociclib Maintains Long-Term Disease Control in HR+ HER2 Metastatic Breast Cancer
Clinical Trials
9 December 2025
Preoperative Radiation May Improve Immune Response in HR+ HER2- Breast Cancer
Clinical Trials
11 December 2025